Trade Summary

1 week ago, Troendle August J., serving as President & CEO at Medpace Holdings, Inc. (MEDP), sold 7,238 shares at $600.44 per share, for a total transaction value of $4,346,003.90. Following this transaction, Troendle August J. now holds 638,946 shares of MEDP.

This sale represents a 1.12% decrease in Troendle August J.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, July 27, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 29, 2026 at 4:36 PM ET, 2 days after the trade was made.

Medpace Holdings, Inc. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.